ロード中...
Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model
BACKGROUND: A recent recalibration of the ONCOTYROL Prostate Cancer Outcome and Policy (PCOP) Model, assuming that latent prostate cancer (PCa) detectable at autopsy might be detectable by screening as well, resulted in considerable worsening of the benefit-harm balance of screening. In this study,...
保存先:
| 出版年: | BMC Public Health |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5485506/ https://ncbi.nlm.nih.gov/pubmed/28651567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-017-4439-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|